Bhatia R - Search Results

1

Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells.

Heaney NB, Pellicano F, Zhang B, Crawford L, Chu S, Kazmi SM, Allan EK, Jorgensen HG, Irvine AE, Bhatia R, Holyoake TL. Heaney NB, et al. Among authors: bhatia r. Blood. 2010 Mar 18;115(11):2241-50. doi: 10.1182/blood-2008-06-164582. Epub 2010 Jan 12. Blood. 2010. PMID: 20068223 Free PMC article.

2

Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.

Bhatia R, McGlave PB, Dewald GW, Blazar BR, Verfaillie CM. Bhatia R, et al. Blood. 1995 Jun 15;85(12):3636-45. Blood. 1995. PMID: 7780147 Free article.

3

Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia.

Bhatia R, McCarthy JB, Verfaillie CM. Bhatia R, et al. Blood. 1996 May 1;87(9):3883-91. Blood. 1996. PMID: 8611716 Free article.

4

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.

Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB. Verfaillie CM, et al. Among authors: bhatia r. Blood. 1996 Jun 1;87(11):4770-9. Blood. 1996. PMID: 8639848 Free article.

5

Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors.

Bhatia R, Verfaillie CM. Bhatia R, et al. Blood. 1998 May 1;91(9):3414-22. Blood. 1998. PMID: 9558400 Free article.

6

Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.

Verfaillie CM, Bhatia R, Steinbuch M, DeFor T, Hirsch B, Miller JS, Weisdorf D, McGlave PB. Verfaillie CM, et al. Among authors: bhatia r. Blood. 1998 Sep 1;92(5):1820-31. Blood. 1998. PMID: 9716614 Free article.

7

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation.

Holtz MS, Slovak ML, Zhang F, Sawyers CL, Forman SJ, Bhatia R. Holtz MS, et al. Among authors: bhatia r. Blood. 2002 May 15;99(10):3792-800. doi: 10.1182/blood.v99.10.3792. Blood. 2002. PMID: 11986238 Free article.

8

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.

Bhatia R, Holtz M, Niu N, Gray R, Snyder DS, Sawyers CL, Arber DA, Slovak ML, Forman SJ. Bhatia R, et al. Blood. 2003 Jun 15;101(12):4701-7. doi: 10.1182/blood-2002-09-2780. Epub 2003 Feb 6. Blood. 2003. PMID: 12576334 Free article.

9

BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells.

Chu S, Holtz M, Gupta M, Bhatia R. Chu S, et al. Among authors: bhatia r. Blood. 2004 Apr 15;103(8):3167-74. doi: 10.1182/blood-2003-04-1271. Epub 2003 Dec 11. Blood. 2004. PMID: 15070699 Free article.

10

Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.

Ramaraj P, Singh H, Niu N, Chu S, Holtz M, Yee JK, Bhatia R. Ramaraj P, et al. Among authors: bhatia r. Cancer Res. 2004 Aug 1;64(15):5322-31. doi: 10.1158/0008-5472.CAN-03-3656. Cancer Res. 2004. PMID: 15289338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,765 results

Search Page

Filters